Register for a 2 or 3 Day Pass!
Session topics
Accelerating Proof-of-Concept
Strategies: Proof-of-Concept
Data Strategy: Speeding Up Phase II to Slow Down Phase III?
Phase 0 and Early Development
Keynotes:
 Antonio (Tito) Fojo, M.D., Ph.D., Head, Experimental Therapeutics Section, NCI, NIH
|
 Neeta Amin, Pharm D., Director, CVMED Research Unit, Pfizer
|
PRE-CONFERENCE SHORT COURSE
A Reasoned Approach to Proof-of-Concept Decision Making
John Arrowsmith, Ph.D., Science Director, Europe Thomson Life Sciences Consulting
Richard K. Harrison, Ph.D., Scientific Director, North America, Thomson Life Sciences Consulting
FEATURED SPEAKERS
Xiaoyin (Frank) Fan, Vertex Pharmaceuticals
Sean Zhang, Bristol-Myers Squibb
Chan Beals, Merck & Co.
|
Lloyd Dethloff, Pfizer, Inc.
Samuel Blackman, GlaxoSmithKline
Robert Sims, Dendreon Corporation
|